On August 20, 2026, Starling Oncology Management, LLC entered into a $25 million revolving credit facility with Gemino Healthcare Finance, LLC. As of the closing date on August 21, 2026, $4.75 million was outstanding. The facility matures on August 20, 2029, bears interest at Term SOFR plus 3.95%, and is secured by accounts receivable. Starling Oncology operates in the healthcare industry, providing oncology services.